PeptidesFDA Reviews Semax, Epitalon, and DSIP-Related Bulk Substances
FDA’s July advisory presentation examined Semax, Epitalon, and Emideltide/DSIP-related bulk substances, emphasizing identity and evidence gaps.
PeptidesFDA’s July advisory presentation examined Semax, Epitalon, and Emideltide/DSIP-related bulk substances, emphasizing identity and evidence gaps.
DietAn 11-man crossover trial compared short creatine loading, beetroot juice, and placebo across bench press, squat, velocity, muscle oxygenation, and recovery measures.
TrainingA 12-week squat study compared accentuated eccentric training one, two, or three days per week in trained athletes. Most outcomes were similar.
NewsPatrick Moore won the 2026 Texas Pro Men's Open. Review the official top five, split scores, and selected winners from the multi-division event.
PeptidesFDA’s July 2026 advisory review examined specific forms and uses of BPC-157, KPV, TB-500, and MOTS-c after their nominations were withdrawn.
PeptidesFDA published 17 revised draft product-specific guidances for generic peptide development. Here is what they cover—and why they are not approvals.
The community
The articles are the reference — the forum is where it gets real. Cycles, bloodwork, training logs, source talk.